Biography:

Dr. Peter Natesan Pushparaj completed his PhD in Biomedical Sciences at the National University of Singapore (NUS) in 2005. During his Post-Doctoral Studies (2005 to 2011), he had extensively studied signal transduction pathways using Functional Genomics, Immunopharmacology and Systems Immunological Approaches to identify various druggable molecular targets for Rheumatoid Arthritis, Anaphylaxis, Allergy and Asthma that resulted in high impact publications in Tier 1 journals such as Journal of Immunology, Immunology, Journal of Dental Research (Top Journal in Oral Biology and Medicine in the World), Cellular and Molecular Life Sciences (CMLS), FASEB J, Neuroscience etc